Publications

Publications published since 1972 or in press from OUS - Molecular Genetic Studies of Breast and Ovarian Cancer

511 publications found

Publications in press

1. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, Dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Hall P, Czene K et al.
   Genome-wide association analysis identifies three new breast cancer susceptibility loci
   Nat Genet (in press)
   PubMed 22267197
2. Kaveh F, Edvardsen H, Borresen-Dale AL, Kristensen VN, Solvang HK
   Allele-specific disparity in breast cancer
   BMC Med Genomics, 4 (1), 85 (in press)
   PubMed 22188678
3. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland A, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL
   Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
   Proc Natl Acad Sci U S A (in press)
   PubMed 21908711
4. Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO
   High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer
   Int J Cancer (in press)
   PubMed 21935921
5. Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM
   Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
   Breast Cancer Res Treat (in press)
   PubMed 22048815

Publications 2012

1. Enerly E, Bray F, Mellem C, Hansen BT, Kjølberg G, Dahl T, Johannesen TB, Nygård M (2012)
   Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway
   Acta Oncol, 51 (1), 45-50
   PubMed 22047060
2. Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Børresen-Dale AL, Levine AJ, Bargonetti J, Prives C (2012)
   Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
   Cell, 148 (1-2), 244-58
   PubMed 22265415
3. Van Loo P, Nilsen G, Nordgard SH, Vollan HK, Børresen-Dale AL, Kristensen VN, Lingjærde OC (2012)
   Analyzing cancer samples with SNP arrays
   Methods Mol Biol, 802, 57-72
   PubMed 22130873

Publications 2011

1. Anaganti S, Fernández-Cuesta L, Langerød A, Hainaut P, Olivier M (2011)
   p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines
   Cancer Lett, 300 (2), 215-24
   PubMed 21071137
2. Bergamaschi A, Christensen BL, Katzenellenbogen BS (2011)
   Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3?, FOXM1, and a gene signature associated with mitosis
   Breast Cancer Res, 13 (3), R70
   PubMed 21707964
3. Bergamaschi A, Dinapoli R, Greiffenberg D, Henrich B, Johnson I, Mozzanica A, Radicci V, Schmitt B, Shi X, Stoppani L (2011)
   Time-over-threshold readout to enhance the high flux capabilities of single-photon-counting detectors
   J Synchrotron Radiat, 18 (Pt 6), 923-9
   PubMed 21997919
4. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
   Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
   Mol Oncol, 5 (6), 564-76
   PubMed 21917534
5. Borge KS, Børresen-Dale AL, Lingaas F (2011)
   Identification of genetic variation in 11 candidate genes of canine mammary tumour
   Vet Comp Oncol, 9 (4), 241-50
   PubMed 22077404
6. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C et al. (2011)
   Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
   Hum Mol Genet, 20 (16), 3289-303
   PubMed 21596841
7. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresen-Dale AL, Kallioniemi O (2011)
   Identification of fusion genes in breast cancer by paired-end RNA-sequencing
   Genome Biol, 12 (1), R6
   PubMed 21247443
8. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL (2011)
   miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
   PLoS One, 6 (2), e16915
   PubMed 21364938
9. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Deng L, Broaddus R, Lluch A, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB (2011)
   Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
   Clin Proteomics, 8 (1), 11
   PubMed 21906370
10. Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Australian Ovarian Cancer Study Group, Pearson RB, Børresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD (2011)
    Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers
    PLoS One, 6 (4), e18064
    PubMed 21533284
11. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, Wang Y, Kong B, Langerød A, Børresen-Dale AL, Kim SK, van de Vijver M, Sukumar S, Whitfield ML, Kellis M, Xiong Y, Wong DJ, Chang HY (2011)
    Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
    Nat Genet, 43 (7), 621-9
    PubMed 21642992
12. Haakensen VD, Bjøro T, Lüders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Børresen-Dale AL, Helland Å (2011)
    Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
    BMC Cancer, 11, 332
    PubMed 21812955
13. Haakensen VD, Lingjaerde OC, Lüders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, Bukholm IK, Johannesen TB, Perou CM, Ursin G, Kristensen VN, Børresen-Dale AL, Helland A (2011)
    Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
    BMC Med Genomics, 4, 77
    PubMed 22044755
14. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2011)
    DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
    Mol Oncol, 5 (1), 77-92
    PubMed 21169070
15. Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS et al. (2011)
    The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
    Cancer Cell, 19 (2), 273-82
    PubMed 21316605
16. Kristensen VN (2011)
    Divide and conquer: the genetic basis of molecular subclassification of breast cancer
    EMBO Mol Med, 3 (4), 183-5
    PubMed 21394915
17. Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL (2011)
    Blood gene expression profiling of breast cancer survivors experiencing fibrosis
    Int J Radiat Oncol Biol Phys, 79 (3), 875-83
    PubMed 21129856
18. Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, Benítez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC et al. (2011)
    Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
    Cancer Epidemiol Biomarkers Prev, 20 (10), 2222-31
    PubMed 21795498
19. Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
    The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
    Breast Cancer Res, 13 (3), R61
    PubMed 21672237
20. Perou CM, Børresen-Dale AL (2011)
    Systems biology and genomics of breast cancer
    Cold Spring Harb Perspect Biol, 3 (2)
    PubMed 21047916
21. Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
    Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
    Brain Behav Immun, 25 (7), 1376-83
    PubMed 21496483
22. Russnes HG, Kuligina ESh, Suspitsin EN, Voskresenskiy DA, Jordanova ES, Cornelisse CJ, Borresen-Dale AL, Imyanitov EN (2011)
    Paired distribution of molecular subtypes in bilateral breast carcinomas
    Cancer Genet, 204 (2), 96-102
    PubMed 21504707
23. Russnes HG, Navin N, Hicks J, Borresen-Dale AL (2011)
    Insight into the heterogeneity of breast cancer through next-generation sequencing
    J Clin Invest, 121 (10), 3810-8
    PubMed 21965338
24. Rønneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Børresen-Dale AL, Tost J, Kristensen V (2011)
    Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
    Mol Oncol, 5 (1), 61-76
    PubMed 21212030
25. Solvang HK, Lingjærde OC, Frigessi A, Børresen-Dale AL, Kristensen VN (2011)
    Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
    BMC Bioinformatics, 12, 197
    PubMed 21609452
26. Sørlie T (2011)
    How to personalise treatment in early breast cancer
    Eur J Cancer, 47 Suppl 3, S310-1
    PubMed 21943994
27. van den Broek AJ, Broeks A, Horlings HM, Canisius SV, Braaf LM, Langerød A, Van't Veer LJ, Schmidt MK (2011)
    Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
    Breast Cancer Res Treat, 130 (2), 599-608
    PubMed 21667122
28. Westbury CB, Sahlberg KK, Borresen-Dale AL, Isacke CM, Yarnold JR (2011)
    Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients
    Radiat Oncol, 6, 42
    PubMed 21521514
29. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
    Combining gene signatures improves prediction of breast cancer survival
    PLoS One, 6 (3), e17845
    PubMed 21423775

Publications 2010

1. Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Børresen-Dale AL, Pilpel Y, Yakhini Z, Segal E, Yarden Y (2010)
   EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors
   Sci Signal, 3 (124), ra43
   PubMed 20516477
2. Berge EO, Knappskog S, Geisler S, Staalesen V, Pacal M, Børresen-Dale AL, Puntervoll P, Lillehaug JR, Lønning PE (2010)
   Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers
   Mol Cancer, 9, 173
   PubMed 20594292
3. Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P, WECARE Study Collaborative Group (2010)
   Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study
   J Natl Cancer Inst, 102 (7), 475-83
   PubMed 20305132
4. Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, Fagerheim T, Bremnes Y, Chanock SJ, Burdett L, Yeager M, Ursin G, Kristensen VN (2010)
   Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density
   BMC Med Genomics, 3, 9
   PubMed 20302654
5. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerød A, Han W, Noh DY, Jeffrey SS, Huntsman DG, Børresen-Dale AL, Pollack JR (2010)
   Focal amplification and oncogene dependency of GAB2 in breast cancer
   Oncogene, 29 (5), 774-9
   PubMed 19881546
6. Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J, Børresen-Dale AL, Bernstein JL (2010)
   Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study
   Hum Mutat, 31 (3), E1200-40
   PubMed 20104584
7. Borgan E, Sitter B, Lingjærde OC, Johnsen H, Lundgren S, Bathen TF, Sørlie T, Børresen-Dale AL, Gribbestad IS (2010)
   Merging transcriptomics and metabolomics--advances in breast cancer profiling
   BMC Cancer, 10, 628
   PubMed 21080935
8. Borresen-Dale AL (2010)
   Europe's largest Member Association for Cancer Research
   Period. Biol., 112 (4), 483-485
9. Børresen-Dale AL, Sørlie T, Kristensen VN (2010)
   On the molecular biology of breast cancer
   Mol Oncol, 4 (3), 171-3
   PubMed 20483673
10. de Neergaard M, Kim J, Villadsen R, Fridriksdottir AJ, Rank F, Timmermans-Wielenga V, Langerød A, Børresen-Dale AL, Petersen OW, Rønnov-Jessen L (2010)
    Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment
    Am J Pathol, 176 (3), 1229-40
    PubMed 20133812
11. Dejeux E, Rønneberg JA, Solvang H, Bukholm I, Geisler S, Aas T, Gut IG, Børresen-Dale AL, Lønning PE, Kristensen VN, Tost J (2010)
    DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
    Mol Cancer, 9, 68
    PubMed 20338046
12. Dumeaux V, Olsen KS, Nuel G, Paulssen RH, Børresen-Dale AL, Lund E (2010)
    Deciphering normal blood gene expression variation--The NOWAC postgenome study
    PLoS Genet, 6 (3), e1000873
    PubMed 20300640
13. Edvardsen H, Brunsvig PF, Solvang H, Tsalenko A, Andersen A, Syvanen AC, Yakhini Z, Børresen-Dale AL, Olsen H, Aamdal S, Kristensen VN (2010)
    SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
    Pharmacogenomics J, 10 (6), 513-23
    PubMed 20157331
14. Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL (2010)
    Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study
    Breast Cancer Res Treat, 120 (1), 175-83
    PubMed 19597986
15. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010)
    NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
    Mol Cancer, 9, 113
    PubMed 20482849
16. Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB (2010)
    A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
    Clin Proteomics, 6 (4), 129-51
    PubMed 21691416
17. Holstege H, Horlings HM, Velds A, Langerød A, Børresen-Dale AL, van de Vijver MJ, Nederlof PM, Jonkers J (2010)
    BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
    BMC Cancer, 10, 654
    PubMed 21118481
18. Haakensen VD, Biong M, Lingjærde OC, Holmen MM, Frantzen JO, Chen Y, Navjord D, Romundstad L, Lüders T, Bukholm IK, Solvang HK, Kristensen VN, Ursin G, Børresen-Dale AL, Helland A (2010)
    Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
    Breast Cancer Res, 12 (4), R65
    PubMed 20799965
19. International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J et al. (2010)
    International network of cancer genome projects
    Nature, 464 (7291), 993-8
    PubMed 20393554
20. Jovanovic J, Rønneberg JA, Tost J, Kristensen V (2010)
    The epigenetics of breast cancer
    Mol Oncol, 4 (3), 242-54
    PubMed 20627830
21. Kristensen V, Borresen-Dale AL (2010)
    Mutations for the people
    EMBO Mol Med, 2 (5), 143-5
    PubMed 20461736
22. Landmark-Høyvik H, Reinertsen KV, Loge JH, Kristensen VN, Dumeaux V, Fosså SD, Børresen-Dale AL, Edvardsen H (2010)
    The genetics and epigenetics of fatigue
    PM R, 2 (5), 456-65
    PubMed 20656628
23. Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale AL, Engebraaten O, Maelandsmo GM, Gribbestad IS (2010)
    Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
    BMC Cancer, 10, 433
    PubMed 20716336
24. Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F (2010)
    Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
    Mol Oncol, 4 (4), 357-68
    PubMed 20663721
25. Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J (2010)
    Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
    Breast Cancer Res, 12 (1), R3
    PubMed 20056007
26. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T (2010)
    In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome
    PLoS One, 5 (11), e14002
    PubMed 21124964
27. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
    Mol. Oncol., 4 (2), 169
28. Papp J, Kovacs ME, Solyom S, Kasler M, Børresen-Dale AL, Olah E (2010)
    High prevalence of germline STK11 mutations in Hungarian Peutz-Jeghers Syndrome patients
    BMC Med Genet, 11, 169
    PubMed 21118512
29. Pedersen RS, Brasch-Andersen C, Sim SC, Bergmann TK, Halling J, Petersen MS, Weihe P, Edvardsen H, Kristensen VN, Brøsen K, Ingelman-Sundberg M (2010)
    Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
    Eur J Clin Pharmacol, 66 (12), 1199-205
    PubMed 20665013
30. Peng J, Zhu J, Bergamaschi A, Han W, Noh DY, Pollack JR, Wang P (2010)
    REGULARIZED MULTIVARIATE REGRESSION FOR IDENTIFYING MASTER PREDICTORS WITH APPLICATION TO INTEGRATIVE GENOMICS STUDY OF BREAST CANCER
    Ann. Appl. Stat., 4 (1), 53-77
31. Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL, FEMME Consortium (2010)
    Triple-negative breast cancer: present challenges and new perspectives
    Mol Oncol, 4 (3), 209-29
    PubMed 20537966
32. Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL (2010)
    Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
    Mol Oncol, 4 (2), 98-118
    PubMed 20060370
33. Rantala JK, Edgren H, Lehtinen L, Wolf M, Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta P, Iljin K, Kallioniemi O (2010)
    Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2
    Neoplasia, 12 (11), 877-88
    PubMed 21082043
34. Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD (2010)
    Predictors and course of chronic fatigue in long-term breast cancer survivors
    J Cancer Surviv, 4 (4), 405-14
    PubMed 20862614
35. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
    Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
    Sci Transl Med, 2 (38), 38ra47
    PubMed 20592421
36. Rødningen OK, Prescott TE, Hovland R, Eiklid K, Houge G (2010)
    [Determination of chromosome aberrations with the help of DNA arrays]
    Tidsskr Nor Laegeforen, 130 (9), 944-7
    PubMed 20453958
37. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E (2010)
    The importance of gene-centring microarray data
    Lancet Oncol, 11 (8), 719-20; author reply 720-1
    PubMed 20688275
38. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN (2010)
    Allele-specific copy number analysis of tumors
    Proc Natl Acad Sci U S A, 107 (39), 16910-5
    PubMed 20837533
39. Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, Skaane P, Lönneborg A, Sharma P, Børresen-Dale AL (2010)
    Gene expression profiling of peripheral blood cells for early detection of breast cancer
    Breast Cancer Res, 12 (1), R7
    PubMed 20078854

Publications 2009

1. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT (2009)
   Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
   Clin Cancer Res, 15 (11), 3654-62
   PubMed 19470724
2. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
   Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
   Mol Oncol, 3 (5-6), 469-82
   PubMed 19713161
3. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodríguez R, Barbosa-Morais NL, Ponder BA, SEARCH, Low YL, Bingham S, EPIC, Haiman CA, Le Marchand L, MEC, Broeks A, Schmidt MK, ABCS, Hopper J, Southey M, ABCFS, Beckmann MW, Fasching PA, BBCC et al. (2009)
   Association of ESR1 gene tagging SNPs with breast cancer risk
   Hum Mol Genet, 18 (6), 1131-9
   PubMed 19126777
4. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T et al. (2009)
   Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
   Cancer Epidemiol Biomarkers Prev, 18 (5), 1610-6
   PubMed 19423537
5. Geigl JB, Obenauf AC, Waldispuehl-Geigl J, Hoffmann EM, Auer M, Hörmann M, Fischer M, Trajanoski Z, Schenk MA, Baumbusch LO, Speicher MR (2009)
   Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays
   Nucleic Acids Res, 37 (15), e105
   PubMed 19541849
6. Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009)
   A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide
   Clin Cancer Res, 15 (12), 4165-73
   PubMed 19509150
7. Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T, Riggs M, Wang Y, Helland A, Naume B, Dimitrova N, Børresen-Dale AL, Hicks J, Lucito R (2009)
   Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation
   Nucleic Acids Res, 37 (12), e89
   PubMed 19474344
8. Kraggerud SM, Oldenburg J, Alnaes GI, Berg M, Kristensen VN, Fossa SD, Lothe RA (2009)
   Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology
   Pharmacogenet Genomics, 19 (10), 751-9
   PubMed 19741569
9. Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V (2009)
   Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
   Pharmacogenomics J, 9 (5), 333-40
   PubMed 19546881
10. Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O (2009)
    Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
    Oncogene, 28 (44), 3926-36
    PubMed 19684618
11. Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale AL (2009)
    Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer
    Expert Rev Anticancer Ther, 9 (8), 1115-23
    PubMed 19671031
12. Muggerud AA, Edgren H, Wolf M, Kleivi K, Dejeux E, Tost J, Sørlie T, Kallioniemi O (2009)
    Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
    BMC Med Genomics, 2, 26
    PubMed 19432969
13. Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, Børresen-Dale AL, Mills GB (2009)
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis
    PLoS One, 4 (5), e5583
    PubMed 19440550
14. Olivier M, Petitjean A, Teague J, Forbes S, Dunnick JK, den Dunnen JT, Langerød A, Wilkinson JM, Vihinen M, Cotton RG, Hainaut P, IARC, EC FP6 (2009)
    Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration
    Hum Mutat, 30 (3), 275-82
    PubMed 19006239
15. Prescott TE, Rødningen OK, Bjørnstad A, Stray-Pedersen A (2009)
    Two brothers with a microduplication including the MECP2 gene: rapid head growth in infancy and resolution of susceptibility to infection
    Clin Dysmorphol, 18 (2), 78-82
    PubMed 19057379
16. Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, Gervin K, Ormerod E, Egeland T, Undlien DE (2009)
    X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene
    J Clin Endocrinol Metab, 94 (10), 4086-93
    PubMed 19773398
17. Solvang HK, Nagahara Y, Araki S, Sawada H, Makino S (2009)
    Frequency-Domain Pearson Distribution Approach for Independent Component Analysis (FD-Pearson-ICA) in Blind Source Separation
    IEEE Trans. Audio Speech Lang. Process., 17 (4), 639-649
18. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP, Langerød A, Russnes HE et al. (2009)
    Complex landscapes of somatic rearrangement in human breast cancer genomes
    Nature, 462 (7276), 1005-10
    PubMed 20033038
19. Sun W, Wright FA, Tang Z, Nordgard SH, Van Loo P, Yu T, Kristensen VN, Perou CM (2009)
    Integrated study of copy number states and genotype calls using high-density SNP arrays
    Nucleic Acids Res, 37 (16), 5365-77
    PubMed 19581427
20. Sørlie T (2009)
    Introducing molecular subtyping of breast cancer into the clinic?
    J Clin Oncol, 27 (8), 1153-4
    PubMed 19204193
21. Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A (2009)
    Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
    Mol Oncol, 3 (3), 214-9
    PubMed 19403344

Publications 2008

1. Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J (2008)
   A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
   Acta Oncol, 47 (4), 600-7
   PubMed 18465328
2. Baumbusch LO, Aarøe J, Johansen FE, Hicks J, Sun H, Bruhn L, Gunderson K, Naume B, Kristensen VN, Liestøl K, Børresen-Dale AL, Lingjaerde OC (2008)
   Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
   BMC Genomics, 9, 379
   PubMed 18691401
3. Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR (2008)
   CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
   Mol Oncol, 2 (4), 327-39
   PubMed 19383354
4. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL (2008)
   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
   J Pathol, 214 (3), 357-67
   PubMed 18044827
5. Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Børresen-Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V (2008)
   p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation
   Mol Syst Biol, 4, 229
   PubMed 19034270
6. Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL, Women's Environment, Cancer, and Radiation Epidemiology Study Collaborative Group (2008)
   Variants in the ATM gene associated with a reduced risk of contralateral breast cancer
   Cancer Res, 68 (16), 6486-91
   PubMed 18701470
7. Dumeaux V, Børresen-Dale AL, Frantzen JO, Kumle M, Kristensen VN, Lund E (2008)
   Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
   Breast Cancer Res, 10 (1), R13
   PubMed 18271962
8. Dumeaux V, Lund E, Børresen-Dale AL (2008)
   Comparison of globin RNA processing methods for genome-wide transcriptome analysis from whole blood
   Biomark Med, 2 (1), 11-21
   PubMed 20477359
9. Holm R, Kraus I, Skomedal H, Langerød A, Kristensen GB, Lyng H (2008)
   Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma
   Open Virol J, 2, 74-81
   PubMed 19440467
10. Horlings HM, Bergamaschi A, Nordgard SH, Kim YH, Han W, Noh DY, Salari K, Joosse SA, Reyal F, Lingjaerde OC, Kristensen VN, Børresen-Dale AL, Pollack J, van de Vijver MJ (2008)
    ESR1 gene amplification in breast cancer: a common phenomenon?
    Nat Genet, 40 (7), 807-8; author reply 810-2
    PubMed 18583965
11. Kristensen VN, Børresen-Dale AL (2008)
    SNPs associated with molecular subtypes of breast cancer: on the usefulness of stratified Genome-wide Association Studies (GWAS) in the identification of novel susceptibility loci
    Mol Oncol, 2 (1), 12-5
    PubMed 19383324
12. Kulle B, Frigessi A, Edvardsen H, Kristensen V, Wojnowski L (2008)
    Accounting for haplotype phase uncertainty in linkage disequilibrium estimation
    Genet Epidemiol, 32 (2), 168-78
    PubMed 17968987
13. Lund E, Dumeaux V, Braaten T, Hjartåker A, Engeset D, Skeie G, Kumle M (2008)
    Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft
    Int J Epidemiol, 37 (1), 36-41
    PubMed 17644530
14. Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD, WECARE Study Collaborative Group, Bernstein JL (2008)
    Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    Br J Cancer, 98 (4), 728-33
    PubMed 18253122
15. Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, Sørlie T, Lønning PE, Børresen-Dale AL, Kristensen VN (2008)
    Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival
    Int J Cancer, 123 (3), 577-85
    PubMed 18498133
16. Nordgard SH, Johansen FE, Alnaes GI, Bucher E, Syvänen AC, Naume B, Børresen-Dale AL, Kristensen VN (2008)
    Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients
    Genes Chromosomes Cancer, 47 (8), 680-96
    PubMed 18398821
17. Nørsett KG, Laegreid A, Kusnierczyk W, Langaas M, Ylving S, Fossmark R, Myhre S, Falkmer S, Waldum HL, Sandvik AK (2008)
    Changes in gene expression of gastric mucosa during therapeutic acid inhibition
    Eur J Gastroenterol Hepatol, 20 (7), 613-23
    PubMed 18679062
18. Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, Wessels LF, Jonkers J, van de Vijver MJ, van Lohuizen M (2008)
    EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
    Breast Cancer Res, 10 (6), R109
    PubMed 19099573
19. Roca X, Olson AJ, Rao AR, Enerly E, Kristensen VN, Børresen-Dale AL, Andresen BS, Krainer AR, Sachidanandam R (2008)
    Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics
    Genome Res, 18 (1), 77-87
    PubMed 18032726
20. Rødningen OK, Børresen-Dale AL, Alsner J, Hastie T, Overgaard J (2008)
    Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis
    Radiother Oncol, 86 (3), 314-20
    PubMed 17963910
21. Rønneberg JA, Tost J, Solvang HK, Alnaes GI, Johansen FE, Brendeford EM, Yakhini Z, Gut IG, Lønning PE, Børresen-Dale AL, Gabrielsen OS, Kristensen VN (2008)
    GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas
    Cancer Res, 68 (14), 5562-71
    PubMed 18632608
22. Saebo S, Almoy T, Aaroe J, Aastveit AH (2008)
    ST-PLS: a multi-directional nearest shrunken centroid type classi er via PLS
    J. Chemometr., 22 (1-2), 54-62
23. Solvang HK, Ishizuka K, Fujimoto M (2008)
    Voice activity detection based on adjustable linear prediction and GARCH models
    Speech Commun., 50 (6), 476-486
24. Suspitsin EN, Due EU, Vu P, Hirvonen A, Børresen-Dale AL, Imyanitov EN (2008)
    TP53 mutations in synchronous and metachronous bilateral breast carcinomas
    Cancer Genet Cytogenet, 184 (2), 119-21
    PubMed 18617062
25. Tongbai R, Idelman G, Nordgard SH, Cui W, Jacobs JL, Haggerty CM, Chanock SJ, Børresen-Dale AL, Livingston G, Shaunessy P, Chiang CH, Kristensen VN, Bilke S, Gardner K (2008)
    Transcriptional networks inferred from molecular signatures of breast cancer
    Am J Pathol, 172 (2), 495-509
    PubMed 18187569
26. Vaclavikova R, Nordgard SH, Alnaes GI, Hubackova M, Kubala E, Kodet R, Mrhalova M, Novotny J, Gut I, Kristensen VN, Soucek P (2008)
    Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients
    Pharmacogenet Genomics, 18 (3), 263-73
    PubMed 18300948
27. Waaseth M, Bakken K, Dumeaux V, Olsen KS, Rylander C, Figenschau Y, Lund E (2008)
    Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis
    BMC Womens Health, 8, 1
    PubMed 18194511

Publications 2007

1. Alsner J, Rødningen OK, Overgaard J (2007)
   Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis
   Radiother Oncol, 83 (3), 261-6
   PubMed 17512072
2. Brunsvig PF, Andersen A, Aamdal S, Kristensen V, Olsen H (2007)
   Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
   BMC Cancer, 7, 197
   PubMed 17956601
3. Casalini P, Iorio MV, Berno V, Bergamaschi A, Børresen Dale AL, Gasparini P, Orlandi R, Casati B, Tagliabue E, Ménard S (2007)
   Relationship between p53 and p27 expression following HER2 signaling
   Breast, 16 (6), 597-605
   PubMed 17604627
4. Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007)
   Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
   Breast Cancer Res, 9 (1), R5
   PubMed 17224074
5. Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B, Helland A, Børresen-Dale AL, Fosså SD (2007)
   Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy
   Int J Radiat Oncol Biol Phys, 67 (4), 1163-71
   PubMed 17336217
6. Edvardsen H, Tefre T, Jansen L, Vu P, Haffty BG, Fosså SD, Kristensen VN, Børresen-Dale AL (2007)
   Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
   Radiat Oncol, 2, 25
   PubMed 17623063
7. Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S (2007)
   Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer
   Int J Cancer, 121 (11), 2532-8
   PubMed 17683073
8. Garcia-Closas M, Troester MA, Qi Y, Langerød A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS, Gram IT, Kristensen V, Børresen-Dale AL, Chanock S, Perou CM (2007)
   Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status
   Cancer Epidemiol Biomarkers Prev, 16 (11), 2269-75
   PubMed 18006915
9. Irish JM, Anensen N, Hovland R, Skavland J, Børresen-Dale AL, Bruserud O, Nolan GP, Gjertsen BT (2007)
   Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53
   Blood, 109 (6), 2589-96
   PubMed 17105820
10. Kapp AV, Jeffrey SS, Langerod A, Borresen-Dale AL, Han W, Noh DY, Bukholm IRK, Nicolau M, Brown PO, Tibshirani R (2007)
    Discovery and validation of breast cancer subtypes (vol 8, pg 101, 2007)
    BMC Genomics, 8, 101
11. Kellen E, Hemelt M, Broberg K, Golka K, Kristensen VN, Hung RJ, Matullo G, Mittal RD, Porru S, Povey A, Schulz WA, Shen J, Buntinx F, Zeegers MP, Taioli E (2007)
    Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review
    Am J Epidemiol, 165 (11), 1221-30
    PubMed 17404387
12. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, Nesland JM, Myklebost O, Rognum TO, Giercksky KE, Skotheim RI, Lothe RA (2007)
    Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
    Mol Cancer, 6, 2
    PubMed 17201907
13. Knappskog S, Chrisanthar R, Staalesen V, Børresen-Dale AL, Gram IT, Lillehaug JR, Lønning PE (2007)
    Mutations and polymorphisms of the p21B transcript in breast cancer
    Int J Cancer, 121 (4), 908-10
    PubMed 17443496
14. Landmark H, Nahas SA, Aarøe J, Gatti R, Børresen-Dale AL, Rødningen OK (2007)
    Transcriptional response to ionizing radiation in human radiation sensitive cell lines
    Radiother Oncol, 83 (3), 256-60
    PubMed 17512073
15. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
    Breast Cancer Res, 9 (3), R30
    PubMed 17504517
16. Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M (2007)
    Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study
    Int J Cancer, 121 (3), 645-8
    PubMed 17372914
17. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
    Mol Oncol, 1 (2), 160-71
    PubMed 19383292
18. Nicolau M, Tibshirani R, Børresen-Dale AL, Jeffrey SS (2007)
    Disease-specific genomic analysis: identifying the signature of pathologic biology
    Bioinformatics, 23 (8), 957-65
    PubMed 17277331
19. Nordgard SH, Johansen FE, Alnaes GI, Naume B, Børresen-Dale AL, Kristensen VN (2007)
    Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
    Breast Cancer Res, 9 (6), 113
    PubMed 18036273
20. Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lønning PE, Børresen-Dale AL, Kristensen VN (2007)
    ABCB1 and GST polymorphisms associated with TP53 status in breast cancer
    Pharmacogenet Genomics, 17 (2), 127-36
    PubMed 17301692
21. Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, Li D, Parl FF, Rylander-Rudqvist T, Soucek P, Zheng W, Wedren S, Taioli E (2007)
    Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review
    Am J Epidemiol, 165 (2), 115-25
    PubMed 17053044
22. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M (2007)
    TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    Oncogene, 26 (15), 2157-65
    PubMed 17401424
23. Riise R, Ygge J, Lindman C, Stray-Pedersen A, Bek T, Rødningen OK, Heiberg A (2007)
    Ocular findings in Norwegian patients with ataxia-telangiectasia: a 5 year prospective cohort study
    Acta Ophthalmol Scand, 85 (5), 557-62
    PubMed 17376192
24. Stray-Pedersen A, Borresen-Dale AL, Paus E, Lindman CR, Burgers T, Abrahamsen TG (2007)
    Alpha fetoprotein is increasing with age in ataxia-telangiectasia
    Eur J Paediatr Neurol, 11 (6), 375-80
    PubMed 17540590
25. Størvold GL, Gjernes E, Askautrud HA, Børresen-Dale AL, Perou CM, Frengen E (2007)
    A retroviral vector for siRNA expression in mammalian cells
    Mol Biotechnol, 35 (3), 275-82
    PubMed 17652791
26. Suspitsin EN, Sokolenko AP, Togo AV, Lazareva YR, Turkevich EA, Matsko DE, Henrich KO, Borresen-Dale AL, Schwab M, Cornelisse CJ, Imyanitov EN (2007)
    Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias
    Int J Cancer, 120 (2), 297-302
    PubMed 17066426
27. Sørlie T (2007)
    Molecular classification of breast tumors: toward improved diagnostics and treatments
    Methods Mol Biol, 360, 91-114
    PubMed 17172726
28. Wang Y, Kristensen GB, Børresen-Dale AL, Helland A (2007)
    TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients
    Ann Oncol, 18 (5), 964-6
    PubMed 17488735
29. Yosef N, Yakhini Z, Tsalenko A, Kristensen V, Børresen-Dale AL, Ruppin E, Sharan R (2007)
    A supervised approach for identifying discriminating genotype patterns and its application to breast cancer data
    Bioinformatics, 23 (2), e91-8
    PubMed 17237111

Publications 2006

1. Anensen N, Skavland J, Stapnes C, Ryningen A, Børresen-Dale AL, Gjertsen BT, Bruserud Ø (2006)
   Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report
   Leukemia, 20 (4), 734-6
   PubMed 16437140
2. Baumbusch LO, Myhre S, Langerød A, Bergamaschi A, Geisler SB, Lønning PE, Deppert W, Dornreiter I, Børresen-Dale AL (2006)
   Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters
   Mol Cancer, 5, 47
   PubMed 17054774
3. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR (2006)
   Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
   Genes Chromosomes Cancer, 45 (11), 1033-40
   PubMed 16897746
4. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A, Børresen-Dale AL, Giaccia A, Longaker MT, Hastie T, Yang GP, van de Vijver MJ, Brown PO (2006)
   Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers
   PLoS Med, 3 (3), e47
   PubMed 16417408
5. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA (2006)
   The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes
   Genes Chromosomes Cancer, 45 (1), 31-41
   PubMed 16145679
6. Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G (2006)
   Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
   Int J Cancer, 118 (11), 2877-81
   PubMed 16381016
7. Dumeaux V, Johansen J, Børresen-Dale AL, Lund E (2006)
   Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy
   Mol Cancer Ther, 5 (4), 868-76
   PubMed 16648556
8. Edvardsen H, Irene Grenaker Alnaes G, Tsalenko A, Mulcahy T, Yuryev A, Lindersson M, Lien S, Omholt S, Syvänen AC, Børresen-Dale AL, Kristensen VN (2006)
   Experimental validation of data mined single nucleotide polymorphisms from several databases and consecutive dbSNP builds
   Pharmacogenet Genomics, 16 (3), 207-17
   PubMed 16495780
9. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundán T, Mannermaa A, Børresen-Dale AL, Borg A, Barkardottir RB, Petrini J, Winqvist R (2006)
   RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
   Carcinogenesis, 27 (8), 1593-9
   PubMed 16474176
10. Helland A, Johnsen H, Frøyland C, Landmark HB, Saetersdal AB, Holmen MM, Gjertsen T, Nesland JM, Ottestad W, Jeffrey SS, Ottestad LO, Rodningen OK, Sherlock G, Børresen-Dale AL (2006)
    Radiation-induced effects on gene expression: an in vivo study on breast cancer
    Radiother Oncol, 80 (2), 230-5
    PubMed 16890317
11. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Børresen-Dale AL, Naume B, Schlicting E, Norton L, Hägerström T, Skoog L, Auer G, Månér S, Lundin P, Zetterberg A (2006)
    Novel patterns of genome rearrangement and their association with survival in breast cancer
    Genome Res, 16 (12), 1465-79
    PubMed 17142309
12. Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R (2006)
    Discovery and validation of breast cancer subtypes
    BMC Genomics, 7, 231
    PubMed 16965636
13. Kleivi K (2006)
    Advances in the genetics and epigenetics of gene regulation and human disease
    Genome Biol, 7 (8), 325
    PubMed 16934107
14. Kristensen VN, Edvardsen H, Tsalenko A, Nordgard SH, Sørlie T, Sharan R, Vailaya A, Ben-Dor A, Lønning PE, Lien S, Omholt S, Syvänen AC, Yakhini Z, Børresen-Dale AL (2006)
    Genetic variation in putative regulatory loci controlling gene expression in breast cancer
    Proc Natl Acad Sci U S A, 103 (20), 7735-40
    PubMed 16684880
15. Kristensen VN, Tsalenko A, Geisler J, Faldaas A, Grenaker GI, Lingjaerde OC, Fjeldstad S, Yakhini Z, Lønning PE, Børresen-Dale AL (2006)
    Multilocus analysis of SNP and metabolic data within a given pathway
    BMC Genomics, 7, 5
    PubMed 16412218
16. Lahermo P, Liljedahl U, Alnaes G, Axelsson T, Brookes AJ, Ellonen P, Groop PH, Halldén C, Holmberg D, Holmberg K, Keinänen M, Kepp K, Kere J, Kiviluoma P, Kristensen V, Lindgren C, Odeberg J, Osterman P, Parkkonen M, Saarela J, Sterner M, Strömqvist L, Talas U, Wessman M, Palotie A et al. (2006)
    A quality assessment survey of SNP genotyping laboratories
    Hum Mutat, 27 (7), 711-4
    PubMed 16786507
17. Langholz B, Bernstein JL, Bernstein L, Olsen JH, Børresen-Dale AL, Rosenstein BS, Gatti RA, WECARE Study Collaborative Group, Concannon P (2006)
    On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer
    Int J Cancer, 119 (3), 724-5
    PubMed 16496408
18. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
    ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
    Cell Oncol, 28 (5-6), 259-72
    PubMed 17167179
19. Lønning PE, Børresen-Dale AL (2006)
    Interaction between p53 staining and high-dose chemotherapy in breast cancer
    Clin Cancer Res, 12 (7 Pt 1), 2289
    PubMed 16609046
20. Muggerud AA, Johnsen H, Barnes DA, Steel A, Lønning PE, Naume B, Sørlie T, Børresen-Dale AL (2006)
    Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes
    BMC Cancer, 6, 59
    PubMed 16536878
21. Myhre S, Tveit H, Mollestad T, Laegreid A (2006)
    Additional gene ontology structure for improved biological reasoning
    Bioinformatics, 22 (16), 2020-7
    PubMed 16787968
22. Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL (2006)
    The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
    Clin Cancer Res, 12 (4), 1157-67
    PubMed 16489069
23. Ribeiro FR, Henrique R, Hektoen M, Berg M, Jerónimo C, Teixeira MR, Lothe RA (2006)
    Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas
    Mol Cancer, 5, 33
    PubMed 16952311
24. Staalesen V, Knappskog S, Chrisanthar R, Nordgard SH, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Gram IT, Kristensen VN, Børresen-Dale AL, Lillehaug JR, Lønning PE (2006)
    The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer
    Clin Cancer Res, 12 (20 Pt 1), 6000-4
    PubMed 17062672
25. Sørlie T, Perou CM, Fan C, Geisler S, Aas T, Nobel A, Anker G, Akslen LA, Botstein D, Børresen-Dale AL, Lønning PE (2006)
    Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
    Mol Cancer Ther, 5 (11), 2914-8
    PubMed 17121939
26. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL (2006)
    Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
    BMC Genomics, 7, 127
    PubMed 16729877
27. Tavtigian SV, Pierotti MA, Børresen-Dale AL (2006)
    International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'
    Breast Cancer Res, 8 (6), 303
    PubMed 17096863
28. Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomäki K, Blomqvist C, Børresen-Dale AL, Nevanlinna H (2006)
    ATM variants and cancer risk in breast cancer patients from Southern Finland
    BMC Cancer, 6, 209
    PubMed 16914028
29. Tsalenko A, Sharan R, Kristensen V, Edvardsen H, Børresen-Dale AL, Ben-Dor A, Yakhini Z (2006)
    Analysis of SNP-expression association matrices
    J Bioinform Comput Biol, 4 (2), 259-74
    PubMed 16819783
30. Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MMO, Olivier M, Skomedal H, Hainaut P, Trope CG, Abeler VM, Nesland JM, Borresen-Dale AL, Helland A (2006)
    Effect of the codon 72 polymorphism (c.215G > C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma (vol 24, pg 21, 2004)
    Hum. Mutat., 27 (2), 209-210

Publications 2005

1. Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Børresen-Dale AL, Dumanski JP (2005)
   High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas
   Genes Chromosomes Cancer, 42 (3), 228-37
   PubMed 15578687
2. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ (2005)
   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
   Proc Natl Acad Sci U S A, 102 (10), 3738-43
   PubMed 15701700
3. Come SE, Buzdar AU, Ingle JN, Arteaga CL, Brodie AM, Colditz GA, Johnston SR, Kristensen VN, Lønning PE, McDonnell DP, Osborne CK, Russo J, Santen RJ, Yee D, Hart CS (2005)
   Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement
   Clin Cancer Res, 11 (2 Pt 2), 861s-4s
   PubMed 15701878
4. Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F (2005)
   Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
   Cancer Causes Control, 16 (5), 537-44
   PubMed 15986108
5. Kleivi K, Diep CB, Pandis N, Heim S, Teixeira MR, Lothe RA (2005)
   TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas
   J Pathol, 207 (1), 14-9
   PubMed 16007576
6. Kringen P, Bergamaschi A, Due EU, Wang Y, Tagliabue E, Nesland JM, Nehman A, Tönisson N, Børresen-Dale AL (2005)
   Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas
   Biotechniques, 39 (5), 755-61
   PubMed 16312222
7. Kringen P, Wang Y, Dumeaux V, Nesland JM, Kristensen G, Borresen-Dale AL, Dorum A (2005)
   TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
   BMC Cancer, 5, 134
   PubMed 16229746
8. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
   Clin Cancer Res, 11 (2 Pt 2), 878s-83s
   PubMed 15701881
9. Kristensen VN, Sørlie T, Geisler J, Yoshimura N, Linegjaerde OC, Glad I, Frigessi A, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer
   J Steroid Biochem Mol Biol, 95 (1-5), 105-11
   PubMed 16023338
10. Lingjaerde OC, Baumbusch LO, Liestøl K, Glad IK, Børresen-Dale AL (2005)
    CGH-Explorer: a program for analysis of array-CGH data
    Bioinformatics, 21 (6), 821-2
    PubMed 15531610
11. Lønning PE, Sørlie T, Børresen-Dale AL (2005)
    Genomics in breast cancer-therapeutic implications
    Nat Clin Pract Oncol, 2 (1), 26-33
    PubMed 16264853
12. Maguire P, Margolin S, Skoglund J, Sun XF, Gustafsson JA, Børresen-Dale AL, Lindblom A (2005)
    Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer
    Breast Cancer Res Treat, 94 (2), 145-52
    PubMed 16261413
13. Olsen JH, Hahnemann JM, Børresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarström L, Robsahm TE, Kääriäinen H, Bregård A, Brøndum-Nielsen K, Yuen J, Tucker M (2005)
    Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
    Br J Cancer, 93 (2), 260-5
    PubMed 15942625
14. Rødningen OK, Overgaard J, Alsner J, Hastie T, Børresen-Dale AL (2005)
    Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts
    Radiother Oncol, 77 (3), 231-40
    PubMed 16297999
15. Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, Berner A, Goldberg I, Givant-Horwitz V, Tropè CG, Kristensen GB, Nesland JM, Børresen-Dale AL (2005)
    Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Mol Cancer, 4, 26
    PubMed 16042759
16. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Børresen-Dale AL, Lönneborg A (2005)
    Early detection of breast cancer based on gene-expression patterns in peripheral blood cells
    Breast Cancer Res, 7 (5), R634-44
    PubMed 16168108
17. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL (2005)
    Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis
    Methods Mol Biol, 291, 207-16
    PubMed 15502225
18. Tsalenko A, Sharan R, Edvardsen H, Kristensen V, Børresen-Dale AL, Ben-Dor A, Yakhini Z (2005)
    Analysis of SNP-expression association matrices
    Proc IEEE Comput Syst Bioinform Conf, 135-43
    PubMed 16447971
19. Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL (2005)
    PIK3CA mutations in advanced ovarian carcinomas
    Hum Mutat, 25 (3), 322
    PubMed 15712344
20. Wang Y, Kristensen GB, Helland A, Nesland JM, Børresen-Dale AL, Holm R (2005)
    Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
    Am J Clin Pathol, 124 (3), 392-401
    PubMed 16191507
21. Wolf M, Edgren H, Muggerud A, Kilpinen S, Huusko P, Sørlie T, Mousses S, Kallioniemi O (2005)
    NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer
    Cell Oncol, 27 (3), 169-73
    PubMed 16037637
22. Aas T, Geisler S, Helle H, Børresen-Dale AL, Lønning PE, Akslen LA (2005)
    Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin
    Oncol Rep, 13 (3), 525-30
    PubMed 15706428

Publications 2004

1. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD, WECARE study (2004)
   Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study
   Breast Cancer Res, 6 (3), R199-214
   PubMed 15084244
2. Dumeaux V, Lund E, Hjartåker A (2004)
   Use of oral contraceptives, alcohol, and risk for invasive breast cancer
   Cancer Epidemiol Biomarkers Prev, 13 (8), 1302-7
   PubMed 15298950
3. Kleivi K, Teixeira MR, Eknaes M, Diep CB, Jakobsen KS, Hamelin R, Lothe RA (2004)
   Genome signatures of colon carcinoma cell lines
   Cancer Genet Cytogenet, 155 (2), 119-31
   PubMed 15571797
4. Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Coutelle C, Daly AK, Muzi G, Dolzan V, Duzhak TG, Farker K, Golka K, Haugen A, Hein DW et al. (2004)
   Association of metabolic gene polymorphisms with tobacco consumption in healthy controls
   Int J Cancer, 110 (2), 266-70
   PubMed 15069692
5. Soucek P, Skjelbred CF, Svendsen M, Kristensen T, Kure EH, Kristensen VN (2004)
   Single-track sequencing for genotyping of multiple SNPs in the N-acetyltransferase 1 (NAT1) gene
   BMC Biotechnol, 4, 28
   PubMed 15563733
6. Stray-Pedersen A, Jónsson T, Heiberg A, Lindman CR, Widing E, Aaberge IS, Borresen-Dale AL, Abrahamsen TG (2004)
   The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents
   Clin Exp Immunol, 137 (1), 179-86
   PubMed 15196260
7. Staalesen V, Falck J, Geisler S, Bartkova J, Børresen-Dale AL, Lukas J, Lillehaug JR, Bartek J, Lønning PE (2004)
   Alternative splicing and mutation status of CHEK2 in stage III breast cancer
   Oncogene, 23 (52), 8535-44
   PubMed 15361853
8. Sørlie T (2004)
   Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
   Eur J Cancer, 40 (18), 2667-75
   PubMed 15571950
9. Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM (2004)
   Cell-type-specific responses to chemotherapeutics in breast cancer
   Cancer Res, 64 (12), 4218-26
   PubMed 15205334
10. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM (2004)
    Mutation of GATA3 in human breast tumors
    Oncogene, 23 (46), 7669-78
    PubMed 15361840
11. Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB (2004)
    TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
    Br J Cancer, 90 (3), 678-85
    PubMed 14760384
12. Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A (2004)
    Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
    Hum Mutat, 24 (1), 21-34
    PubMed 15221786
13. Yoshimura N, Harada N, Bukholm I, Kåresen R, Børresen-Dale AL, Kristensen VN (2004)
    Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
    Breast Cancer Res, 6 (2), R46-55
    PubMed 14979917
14. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS (2004)
    Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
    Mol Biol Cell, 15 (6), 2523-36
    PubMed 15034139
15. Zimarina TC, Kristensen VN, Imianitov EN, Bershte?n LM (2004)
    [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]
    Mol Biol (Mosk), 38 (3), 386-93
    PubMed 15285606

Publications 2003

1. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD, Rosenstein BS, Børresen-Dale AL, Gatti RA, Concannon P, Haile RW, WECARE Study Collaborative Group (2003)
   ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer
   Br J Cancer, 89 (8), 1513-6
   PubMed 14562025
2. Bernstein JL, Teraoka S, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P, WECARE Study Collaborative Group (2003)
   Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer
   Hum Mutat, 21 (5), 542-50
   PubMed 12673797
3. Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G (2003)
   Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time
   Breast Cancer Res Treat, 80 (2), 199-206
   PubMed 12908823
4. Børresen-Dale AL (2003)
   TP53 and breast cancer
   Hum Mutat, 21 (3), 292-300
   PubMed 12619115
5. Børresen-Dale AL (2003)
   Genetic profiling of breast cancer: from molecular portraits to clinical utility
   Int J Biol Markers, 18 (1), 54-6
   PubMed 12699064
6. Dumeaux V, Alsaker E, Lund E (2003)
   Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study
   Int J Cancer, 105 (6), 844-50
   PubMed 12767072
7. Geisler S, Børresen-Dale AL, Johnsen H, Aas T, Geisler J, Akslen LA, Anker G, Lønning PE (2003)
   TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer
   Clin Cancer Res, 9 (15), 5582-8
   PubMed 14654539
8. Haslekås C, Grini PE, Nordgard SH, Thorstensen T, Viken MK, Nygaard V, Aalen RB (2003)
   ABI3 mediates expression of the peroxiredoxin antioxidant AtPER1 gene and induction by oxidative stress
   Plant Mol Biol, 53 (3), 313-26
   PubMed 14750521
9. Haslekås C, Viken MK, Grini PE, Nygaard V, Nordgard SH, Meza TJ, Aalen RB (2003)
   Seed 1-cysteine peroxiredoxin antioxidants are not involved in dormancy, but contribute to inhibition of germination during stress
   Plant Physiol, 133 (3), 1148-57
   PubMed 14526116
10. Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH (2003)
    X chromosome inactivation in cervical cancer patients
    Cancer Genet Cytogenet, 146 (1), 73-6
    PubMed 14499700
11. Langerød A, Strømberg M, Chin K, Kristensen VN, Børresen-Dale AL (2003)
    BUB1 infrequently mutated in human breast carcinomas
    Hum Mutat, 22 (5), 420
    PubMed 14517964
12. Pan-Hammarström Q, Dai S, Zhao Y, van Dijk-Härd IF, Gatti RA, Børresen-Dale AL, Hammarström L (2003)
    ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region
    J Immunol, 170 (7), 3707-16
    PubMed 12646636
13. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO et al. (2003)
    Gene expression patterns in ovarian carcinomas
    Mol Biol Cell, 14 (11), 4376-86
    PubMed 12960427
14. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D (2003)
    Repeated observation of breast tumor subtypes in independent gene expression data sets
    Proc Natl Acad Sci U S A, 100 (14), 8418-23
    PubMed 12829800
15. Soucek P, Gut I, Trneny M, Skovlund E, Grenaker Alnaes G, Kristensen T, Børresen-Dale AL, Kristensen VN (2003)
    Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin
    Eur J Hum Genet, 11 (5), 416-9
    PubMed 12734548
16. Stacy JE, Kausmally L, Simonsen B, Nordgard SH, Alsøe L, Michaelsen TE, Brekke OH (2003)
    Direct isolation of recombinant human antibodies against group B Neisseria meningitidis from scFv expression libraries
    J Immunol Methods, 283 (1-2), 247-59
    PubMed 14659916
17. Aas T, Geisler S, Eide GE, Haugen DF, Varhaug JE, Bassøe AM, Thorsen T, Berntsen H, Børresen-Dale AL, Akslen LA, Lønning PE (2003)
    Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy
    Eur J Cancer, 39 (4), 438-46
    PubMed 12751373

Publications 2002

1. Allinen M, Launonen V, Laake K, Jansen L, Huusko P, Kääriäinen H, Børresen-Dale AL, Winqvist R (2002)
   ATM mutations in Finnish breast cancer patients
   J Med Genet, 39 (3), 192-6
   PubMed 11897822
2. Bernstein JL, Seminara D, Børresen-Dale AL (2002)
   Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
   Breast Cancer Res, 4 (6), 249-52
   PubMed 12473172
3. Børresen AL (2002)
   Mismatch detection using heteroduplex analysis
   Curr Protoc Hum Genet, Chapter 7, Unit 7.3
   PubMed 18428333
4. Farrer M, Skipper L, Berg M, Bisceglio G, Hanson M, Hardy J, Adam A, Gwinn-Hardy K, Aasly J (2002)
   The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population
   Neurosci Lett, 322 (2), 83-6
   PubMed 11958849
5. Jeffrey SS, Fero MJ, Børresen-Dale AL, Botstein D (2002)
   Expression array technology in the diagnosis and treatment of breast cancer
   Mol Interv, 2 (2), 101-9
   PubMed 14993355
6. Kleivi K, Lothe RA, Heim S, Tsarouha H, Kraggerud SM, Pandis N, Papadopoulou A, Andersen J, Jakobsen KS, Teixeira MR (2002)
   Genome profiling of breast cancer cells selected against in vitro shows copy number changes
   Genes Chromosomes Cancer, 33 (3), 304-9
   PubMed 11807988
7. Kringen P, Egedal S, Pedersen JC, Harbitz TB, Tveit KM, Berg K, Børresen-Dale AL, Andersen TI (2002)
   BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system
   Electrophoresis, 23 (24), 4085-91
   PubMed 12481264
8. Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH (2002)
   High frequency of skewed X inactivation in young breast cancer patients
   J Med Genet, 39 (1), 30-3
   PubMed 11826021
9. Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL (2002)
   The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
   Cancer Epidemiol Biomarkers Prev, 11 (12), 1684-8
   PubMed 12496062
10. Passarino G, Cavalleri GL, Lin AA, Cavalli-Sforza LL, Børresen-Dale AL, Underhill PA (2002)
    Different genetic components in the Norwegian population revealed by the analysis of mtDNA and Y chromosome polymorphisms
    Eur J Hum Genet, 10 (9), 521-9
    PubMed 12173029
11. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO (2002)
    Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
    Proc Natl Acad Sci U S A, 99 (20), 12963-8
    PubMed 12297621
12. Soucek P, Sarmanová J, Kristensen VN, Apltauerová M, Gut I (2002)
    Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas
    Int Arch Occup Environ Health, 75 Suppl, S86-92
    PubMed 12397416
13. Zhao H, Hastie T, Whitfield ML, Børresen-Dale AL, Jeffrey SS (2002)
    Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis
    BMC Genomics, 3 (1), 31
    PubMed 12445333

Publications 2001

1. Bjørheim J, Ekstrøm PO, Fossberg E, Børresen-Dale AL, Gaudernack G (2001)
   Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations
   Biotechniques, 30 (5), 972-5
   PubMed 11355359
2. Børresen-Dale AL, Hovig E, Smith-Sørensen B (2001)
   Detection of mutations by denaturing gradient gel electrophoresis
   Curr Protoc Hum Genet, Chapter 7, Unit 7.5
   PubMed 18428306
3. Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A (2001)
   Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas
   Anal Cell Pathol, 23 (2), 45-9
   PubMed 11904459
4. Forus A, Sørlie T, Børresen-Dale AL, Myklebost O (2001)
   [Microarray technology--potential in cancer research]
   Tidsskr Nor Laegeforen, 121 (21), 2498-503
   PubMed 11875927
5. Geisler S, Lønning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Børresen-Dale AL (2001)
   Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
   Cancer Res, 61 (6), 2505-12
   PubMed 11289122
6. Jain AN, Chin K, Børresen-Dale AL, Erikstein BK, Eynstein Lonning P, Kaaresen R, Gray JW (2001)
   Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival
   Proc Natl Acad Sci U S A, 98 (14), 7952-7
   PubMed 11438741
7. Kristensen VN, Børresen-Dale AL, Kristensen T (2001)
   Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite ATAAA repeat
   Hum Mutat, 17 (3), 238-9
   PubMed 11241854
8. Kristensen VN, Harada N, Kristensen T, Borresen-Dale AL (2001)
   [Genetic polymorphism and variability of steroid hormone metabolism: connection with risk of developing breast neoplasms]
   Vopr Onkol, 47 (2), 156-9
   PubMed 11383450
9. Kristensen VN, Kelefiotis D, Kristensen T, Børresen-Dale AL (2001)
   High-throughput methods for detection of genetic variation
   Biotechniques, 30 (2), 318-22, 324, 326 passim
   PubMed 11233601
10. Kristensen VN, Kure EH, Erikstein B, Harada N, Børresen-Dale A (2001)
    Genetic susceptibility and environmental estrogen-like compounds
    Mutat Res, 482 (1-2), 77-82
    PubMed 11535251
11. Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale AL (2001)
    Microarrays in primary breast cancer--lessons from chemotherapy studies
    Endocr Relat Cancer, 8 (3), 259-63
    PubMed 11566617
12. Olsen JH, Hahnemann JM, Børresen-Dale AL, Brøndum-Nielsen K, Hammarström L, Kleinerman R, Kääriäinen H, Lönnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD, Tucker M (2001)
    Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries
    J Natl Cancer Inst, 93 (2), 121-7
    PubMed 11208881
13. Salahshor S, Haixin L, Huo H, Kristensen VN, Loman N, Sjöberg-Margolin S, Borg A, Børresen-Dale AL, Vorechovsky I, Lindblom A (2001)
    Low frequency of E-cadherin alterations in familial breast cancer
    Breast Cancer Res, 3 (3), 199-207
    PubMed 11305955
14. Sandvik AK, Støren O, Nørsett K, Laegreid A, Børresen-Dale AL, Myklebost O (2001)
    [Measurement of gene activity by DNA microarrays]
    Tidsskr Nor Laegeforen, 121 (10), 1225-8
    PubMed 11402749
15. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale AL (2001)
    Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    Proc Natl Acad Sci U S A, 98 (19), 10869-74
    PubMed 11553815
16. Warren W, Hovig E, Smith-Sørensen B, Børresen AL, Fujimura FK, Liu Q, Feng J, Sommer SS (2001)
    Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods
    Curr Protoc Hum Genet, Chapter 7, Unit 7.4
    PubMed 18428305

Publications 2000

1. Braaten O, Rødningen OK, Nordal I, Leren TP (2000)
   The genetic algorithm applied to haplotype data at the LDL receptor locus
   Comput Methods Programs Biomed, 61 (1), 1-9
   PubMed 10660265
2. Bukholm IK, Nesland JM, Børresen-Dale AL (2000)
   Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]
   J Pathol, 190 (1), 15-9
   PubMed 10640987
3. Frengen E, Rocca-Serra P, Shaposhnikov S, Taine L, Thorsen J, Bepoldin C, Krekling M, Lafon D, Aas KK, El Monéim AA, Johansen H, Longy M, Prydz H, Dorion-Bonnet F (2000)
   High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1
   Genomics, 70 (3), 273-85
   PubMed 11161777
4. Frengen E, Zhao B, Howe S, Weichenhan D, Osoegawa K, Gjernes E, Jessee J, Prydz H, Huxley C, de Jong PJ (2000)
   Modular bacterial artificial chromosome vectors for transfer of large inserts into mammalian cells
   Genomics, 68 (2), 118-26
   PubMed 10964509
5. Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA (2000)
   Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival
   Int J Cancer, 88 (2), 217-22
   PubMed 11004671
6. Hellström AC, Blegen H, Malec M, Silfverswärd C, Lystad S, Børresen-Dale AL, Auer G (2000)
   Recurrent fallopian tube carcinoma: TP53 mutation and clinical course
   Int J Gynecol Pathol, 19 (2), 145-51
   PubMed 10782411
7. Hou SM, Ryberg D, Fält S, Deverill A, Tefre T, Børresen AL, Haugen A, Lambert B (2000)
   GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients
   Carcinogenesis, 21 (1), 49-54
   PubMed 10607733
8. Jugessur A, Frost P, Andersen TI, Steine S, Lindblom A, Børresen-Dale AL, Eiken HG (2000)
   Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism
   J Mol Med (Berl), 78 (10), 580-7
   PubMed 11199332
9. Kolpakova E, Frengen E, Stokke T, Olsnes S (2000)
   Organization, chromosomal localization and promoter analysis of the gene encoding human acidic fibroblast growth factor intracellular binding protein
   Biochem J, 352 Pt 3, 629-35
   PubMed 11104667
10. Kristensen VN, Borresen-Dale AL (2000)
    Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism
    Mutat Res, 462 (2-3), 323-33
    PubMed 10767642
11. Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Kåresen R, Kristensen T, Børresen-Dale AL (2000)
    Genetic variants of CYP19 (aromatase) and breast cancer risk
    Oncogene, 19 (10), 1329-33
    PubMed 10713674
12. Liestøl K, Kvittingen EA, Rootwelt H, Dunlop O, Goplen AK, Pedersen JC, Brorson SH, Børresen-Dale AL, Myrvang B, Maehlen J (2000)
    Association between apolipoprotein E genotypes and cancer risk in patients with acquired immunodeficiency syndrome
    Cancer Detect Prev, 24 (5), 496-9
    PubMed 11129992
13. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lönnqvist T, Kääriäinen H, Sankila R, Lähdesmäki A, Hammarström L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, Børresen-Dale AL (2000)
    Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia
    Hum Mutat, 16 (3), 232-46
    PubMed 10980530
14. Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL (2000)
    Screening breast cancer patients for Norwegian ATM mutations
    Br J Cancer, 83 (12), 1650-3
    PubMed 11104561
15. Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y, de Jong PJ (2000)
    Bacterial artificial chromosome libraries for mouse sequencing and functional analysis
    Genome Res, 10 (1), 116-28
    PubMed 10645956
16. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000)
    Molecular portraits of human breast tumours
    Nature, 406 (6797), 747-52
    PubMed 10963602
17. Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale AL, DeAngelis P, Steen HB (2000)
    Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma
    Int J Cancer, 89 (4), 313-24
    PubMed 10956404

Publications 1999

1. Arver B, Claro A, Langerød A, Børresen-Dale AL, Lindblom A (1999)
   BRCA1 screening in patients with a family history of breast or ovarian cancer
   Genet Test, 3 (2), 223-6
   PubMed 10464672
2. Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA (1999)
   Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway
   Genes Chromosomes Cancer, 26 (2), 151-60
   PubMed 10469453
3. Danielsen T, Smith-Sørensen B, Grønlund HA, Hvidsten M, Børresen-Dale AL, Rofstad EK (1999)
   No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines
   Int J Radiat Biol, 75 (9), 1149-60
   PubMed 10528923
4. Ekstrøm PO, Børresen-Dale AL, Qvist H, Giercksky KE, Thilly WG (1999)
   Detection of low-frequency mutations in exon 8 of the TP53 gene by constant denaturant capillary electrophoresis (CDCE)
   Biotechniques, 27 (1), 128-34
   PubMed 10407675
5. Frengen E, Weichenhan D, Zhao B, Osoegawa K, van Geel M, de Jong PJ (1999)
   A modular, positive selection bacterial artificial chromosome vector with multiple cloning sites
   Genomics, 58 (3), 250-3
   PubMed 10373322
6. Graphodatsky AS, Vorobieva NV, Filipenko ML, Voronina EV, Frengen E, Prydz H (1999)
   Assignment of the L11 ribosomal protein gene (RPL11) to human chromosome 1p36.1-->p35 by in situ hybridization
   Cytogenet Cell Genet, 84 (1-2), 97-8
   PubMed 10343117
7. Helland A, Børresen-Dale AL (1999)
   p53 polymorphism and cervical cancer
   Lancet, 354 (9189), 1561-2
   PubMed 10551531
8. Högmo A, Börresen-Dale AL, Blegen H, Lindholm J, Kuylenstierna R, Auer G, Munck-Wikland E (1999)
   TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas
   Anticancer Res, 19 (4C), 3433-8
   PubMed 10629631
9. Laake K, Launonen V, Niederacher D, Gudlaugsdottir S, Seitz S, Rio P, Champème MH, Bièche I, Birnbaum D, White G, Sztan M, Sever N, Plummer S, Osorio A, Broeks A, Huusko P, Spurr N, Borg A, Cleton-Jansen AM, van't Veer L, Benitez J, Casey G, Peterlin B, Olah E, Børresen-Dale AL (1999)
   Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium
   Genes Chromosomes Cancer, 25 (3), 212-21
   PubMed 10379867
10. Matre V, Høvring PI, Orstavik S, Frengen E, Rian E, Velickovic Z, Murray-McIntosh RP, Gautvik KM (1999)
    Structural and functional organization of the gene encoding the human thyrotropin-releasing hormone receptor
    J Neurochem, 72 (1), 40-50
    PubMed 9886052
11. Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL (1999)
    CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1
    Cancer Res, 59 (12), 2825-8
    PubMed 10383140
12. Rødningen OK, Tonstad S, Medh JD, Chappell DA, Ose L, Leren TP (1999)
    Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
    J Lipid Res, 40 (2), 213-20
    PubMed 9925649
13. Rødningen OK, Tonstad S, Saugstad OD, Ose L, Leren TP (1999)
    Mutant transcripts of the LDL receptor gene: mRNA structure and quantity
    Hum Mutat, 13 (3), 186-96
    PubMed 10090473
14. Skammelsrud N, Martin ER, Murphy P, Khuu C, Frengen E, Kolstø AB (1999)
    The gene for human transcription factor TCF11 is located telomeric to D17S1827, BTR and HP1Hsbeta on chromosome 17q22
    Genet Anal, 15 (6), 217-22
    PubMed 10609757
15. Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL (1999)
    Allelic imbalance at chromosome region 11q23 in cervical carcinomas
    Eur J Cancer, 35 (4), 659-63
    PubMed 10492643
16. Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R (1999)
    TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus
    J Pathol, 187 (5), 556-62
    PubMed 10398121
17. van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH (1999)
    Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma
    J Pathol, 189 (4), 504-13
    PubMed 10629550

Publications 1998

1. Adélaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Børresen-Dale AL, Lidereau R, Birnbaum D, Pébusque MJ (1998)
   Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer
   Genes Chromosomes Cancer, 22 (3), 186-99
   PubMed 9624530
2. Andersen TI, Børresen-Dale AL (1998)
   [Diagnostic molecular biology in breast cancer]
   Tidsskr Nor Laegeforen, 118 (15), 2366-9
   PubMed 9691806
3. Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL (1998)
   Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening
   Hum Mutat, 11 (2), 166-74
   PubMed 9482581
4. Bjørheim J, Lystad S, Lindblom A, Kressner U, Westring S, Wahlberg S, Lindmark G, Gaudernack G, Ekstrøm P, Røe J, Thilly WG, Børresen-Dale AL (1998)
   Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction
   Mutat Res, 403 (1-2), 103-12
   PubMed 9726011
5. Bukholm IK, Berner JM, Nesland JM, Børresen-Dale AL (1998)
   Expression of cyclin Ds in relation to p53 status in human breast carcinomas
   Virchows Arch, 433 (3), 223-8
   PubMed 9769125
6. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1998)
   E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma
   J Pathol, 185 (3), 262-6
   PubMed 9771479
7. Børresen-Dale AL, Boman H (1998)
   [Hereditary cancer]
   Tidsskr Nor Laegeforen, 118 (12), 1873-7
   PubMed 9638057
8. Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E (1998)
   TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival
   Clin Cancer Res, 4 (1), 203-10
   PubMed 9516972
9. Børresen-Dale AL, Lothe RA, Nesland JM (1998)
   [Molecular biology. Basis for increased understanding of diseases and improved diagnostics]
   Tidsskr Nor Laegeforen, 118 (11), 1681
   PubMed 9621751
10. Clausen OP, Lothe RA, Børresen-Dale AL, De Angelis P, Chen Y, Rognum TO, Meling GI (1998)
    Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas
    Diagn Mol Pathol, 7 (4), 215-23
    PubMed 9917132
11. Eiken HG, Børresen-Dale AL (1998)
    [Molecular genetic diagnostics. Technology for detecting mutations in DNA]
    Tidsskr Nor Laegeforen, 118 (11), 1730-6
    PubMed 9621763
12. Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale A (1998)
    Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load
    Br J Cancer, 78 (1), 69-72
    PubMed 9662253
13. Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL (1998)
    p53 polymorphism and risk of cervical cancer
    Nature, 396 (6711), 530-1; author reply 532
    PubMed 9859987
14. Helland A, Olsen AO, Gjøen K, Akselsen HE, Sauer T, Magnus P, Børresen-Dale AL, Rønningen KS (1998)
    An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women
    Int J Cancer, 76 (1), 19-24
    PubMed 9533756
15. Kressner U, Bjørheim J, Westring S, Wahlberg SS, Påhlman L, Glimelius B, Lindmark G, Lindblom A, Børresen-Dale AL (1998)
    Ki-ras mutations and prognosis in colorectal cancer
    Eur J Cancer, 34 (4), 518-21
    PubMed 9713302
16. Kristensen T, Kristensen VN, Børresen-Dale AL (1998)
    High-throughput screening for known mutations by automated analysis of single sequencing reactions
    Biotechniques, 24 (5), 832-5
    PubMed 9591134
17. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL (1998)
    A rare CYP19 (aromatase) variant may increase the risk of breast cancer
    Pharmacogenetics, 8 (1), 43-8
    PubMed 9511180
18. Lothe RA, Hektoen M, Johnsen H, Meling GI, Andersen TI, Rognum TO, Lindblom A, Børresen-Dale AL (1998)
    The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer
    Cancer Res, 58 (14), 2923-4
    PubMed 9679946
19. Laake K, Telatar M, Geitvik GA, Hansen RO, Heiberg A, Andresen AM, Gatti R, Børresen-Dale AL (1998)
    Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect
    Eur J Hum Genet, 6 (3), 235-44
    PubMed 9781027
20. Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Børresen-Dale AL (1998)
    Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
    Pharmacogenetics, 8 (5), 441-7
    PubMed 9825836
21. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C (1998)
    Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters
    Cancer Res, 58 (5), 1004-12
    PubMed 9500463
22. Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP (1998)
    Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA
    Hum Mutat, 12 (2), 95-102
    PubMed 9671270
23. Smith-Sørensen B, Kaern J, Holm R, Dørum A, Tropé C, Børresen-Dale AL (1998)
    Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status
    Br J Cancer, 78 (3), 375-81
    PubMed 9703286
24. Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL (1998)
    Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases
    Breast Cancer Res Treat, 48 (3), 259-64
    PubMed 9598872
25. Sørlie T, Bukholm I, Børresen-Dale AL (1998)
    Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online
    Hum Mutat, 12 (3), 215
    PubMed 10660330
26. Sørlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Børresen-Dale AL, Montesano R (1998)
    Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines
    Br J Cancer, 77 (10), 1573-9
    PubMed 9635831
27. Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuszkiewicz E, Porras O, Watanabe M, Junker A, Concannon P, Gatti RA (1998)
    Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations
    Am J Hum Genet, 62 (1), 86-97
    PubMed 9443866

Publications 1997

1. Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL (1997)
   Screening for ESR mutations in breast and ovarian cancer patients
   Hum Mutat, 9 (6), 531-6
   PubMed 9195227
2. Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL, Gaudernack G (1997)
   Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors
   Int J Cancer, 74 (6), 664-9
   PubMed 9421366
3. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
   Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas
   Virchows Arch, 431 (5), 317-21
   PubMed 9463572
4. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
   Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
   Int J Cancer, 73 (1), 38-41
   PubMed 9334807
5. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen AL (1997)
   Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas
   J Pathol, 181 (2), 140-5
   PubMed 9120716
6. Devilee P, Hermans J, Eyfjörd J, Bøorresen AL, Lidereau R, Sobol H, Borg A, Cleton-Jansen AM, Oláh E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon YJ, Maugard C (1997)
   Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium
   Genes Chromosomes Cancer, 18 (3), 193-9
   PubMed 9071572
7. Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M (1997)
   Absence of p21 expression is associated with abnormal p53 in human breast carcinomas
   Br J Cancer, 76 (4), 480-5
   PubMed 9275025
8. Heimdal K, Olsson H, Tretli S, Fosså SD, Børresen AL, Bishop DT (1997)
   A segregation analysis of testicular cancer based on Norwegian and Swedish families
   Br J Cancer, 75 (7), 1084-7
   PubMed 9083348
9. Helland A, Børresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, de la Chapelle A, Lothe RA (1997)
   Microsatellite instability in cervical and endometrial carcinomas
   Int J Cancer, 70 (5), 499-501
   PubMed 9052745
10. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
    A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
    Pathol Res Pract, 193 (7), 471-8
    PubMed 9342752
11. Kristensen VN, Børresen-Dale AL (1997)
    Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide
    Biotechniques, 23 (4), 634-6
    PubMed 9343680
12. Leren TP, Bakken KS, Rødningen OK, Gundersen KE, Sundvold H, Berg K, Tonstad S, Ose L (1997)
    [Application of gene technology in the diagnosis of familial hypercholesterolemia]
    Tidsskr Nor Laegeforen, 117 (5), 678-81
    PubMed 9102960
13. Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rødningen OK, Sundvold H, Ose L, Berg K (1997)
    Molecular genetics of familial hypercholesterolaemia in Norway
    J Intern Med, 241 (3), 185-94
    PubMed 9104431
14. Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL (1997)
    Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM
    Genes Chromosomes Cancer, 18 (3), 175-80
    PubMed 9071570
15. Paulsen T, Aas T, Børresen AL, Varhaug JE, Lønning PE, Akslen LA (1997)
    Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer
    Int J Cancer, 74 (1), 138-40
    PubMed 9036883
16. Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R (1997)
    TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
    J Pathol, 181 (2), 158-65
    PubMed 9120719
17. Tranebjaerg L, Børresen-Dale AL, Hansteen IL, Heim S, Kvittingen EA, Møller P (1997)
    Genetic services in Norway
    Eur J Hum Genet, 5 Suppl 2, 130-4
    PubMed 9450210
18. Zelada-Hedman M, Børresen-Dale AL, Claro A, Chen J, Skoog L, Lindblom A (1997)
    Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families
    Br J Cancer, 75 (8), 1201-4
    PubMed 9099970
19. Zelada-Hedman M, Børresen-Dale AL, Lindblom A (1997)
    Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation
    Hum Mutat, 9 (3), 289
    PubMed 9090537
20. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Håkansson S, Andersen TI, Borg A, Børresen Dale AL, Lindblom A (1997)
    A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region
    Cancer Res, 57 (12), 2474-7
    PubMed 9192828

Publications 1996

1. Andersen TI, Børresen AL, Møller P (1996)
   A common BRCA1 mutation in Norwegian breast and ovarian cancer families?
   Am J Hum Genet, 59 (2), 486-7
   PubMed 8755943
2. Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM (1996)
   TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
   Breast Cancer Res Treat, 41 (2), 103-9
   PubMed 8944328
3. Gundersen KE, Solberg K, Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP (1996)
   Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia
   Clin Genet, 49 (2), 85-7
   PubMed 8740918
4. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
   Familial testicular cancer in Norway and southern Sweden
   Br J Cancer, 73 (7), 964-9
   PubMed 8611416
5. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
   Risk of cancer in relatives of testicular cancer patients
   Br J Cancer, 73 (7), 970-3
   PubMed 8611417
6. Lothe RA, Karhu R, Mandahl N, Mertens F, Saeter G, Heim S, Borresen-Dale AL, Kallioniemi OP (1996)
   Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis
   Cancer Res, 56 (20), 4778-81
   PubMed 8840998
7. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O (1996)
   Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
   Br J Cancer, 73 (8), 909-16
   PubMed 8611425
8. Rødningen OK, Leren TP (1996)
   Application of long polymerase chain reaction in the study of the LDL receptor gene
   Scand J Clin Lab Invest, 56 (1), 93-6
   PubMed 8850178
9. Sundvold H, Solberg K, Tonstad S, Rødningen OK, Ose L, Berg K, Leren TP (1996)
   A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects
   Hum Mutat, 7 (1), 70-1
   PubMed 8664907
10. Zedenius J, Larsson C, Wallin G, Bäckdahl M, Aspenblad U, Höög A, Børresen AL, Auer G (1996)
    Alterations of p53 and expression of WAF1/p21 in human thyroid tumors
    Thyroid, 6 (1), 1-9
    PubMed 8777377
11. Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE (1996)
    Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
    Nat Med, 2 (7), 811-4
    PubMed 8673929
12. Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA (1996)
    Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome
    Acta Oncol, 35 Suppl 5, 5-8
    PubMed 9142957

Publications 1995

1. Andersen TI, Børresen AL (1995)
   Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detection
   Diagn Mol Pathol, 4 (3), 203-11
   PubMed 7493140
2. Andersen TI, Paus E, Nesland JM, McKenzie SJ, Børresen AL (1995)
   Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour
   Acta Oncol, 34 (4), 499-504
   PubMed 7605658
3. Berner A, Geitvik G, Karlsen F, Fosså SD, Nesland JM, Børresen AL (1995)
   TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
   J Pathol, 176 (3), 299-308
   PubMed 7674092
4. Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S (1995)
   TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains
   Genes Chromosomes Cancer, 14 (1), 71-5
   PubMed 8527388
5. Børresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO, Kolodner RD (1995)
   Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas
   Hum Mol Genet, 4 (11), 2065-72
   PubMed 8589682
6. Esteve A, Sørlie T, Martel-Planche G, Hollstein M, Kusters I, Lewalter J, Vineis P, Stephan-Odenthal M, Montesano R (1995)
   Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors
   J Occup Environ Med, 37 (1), 59-68
   PubMed 7620944
7. Friend S, Borresen AL, Brody L, Casey G, Devilee P, Gayther S, Goldgar D, Murphy P, Weber BL, Wiseman R (1995)
   Breast cancer information on the web
   Nat Genet, 11 (3), 238-9
   PubMed 7581445
8. Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen AL (1995)
   Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population
   Cancer Epidemiol Biomarkers Prev, 4 (2), 123-6
   PubMed 7742719
9. Lange E, Borresen AL, Chen X, Chessa L, Chiplunkar S, Concannon P, Dandekar S, Gerken S, Lange K, Liang T (1995)
   Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium
   Am J Hum Genet, 57 (1), 112-9
   PubMed 7611279
10. Leren TP, Rødningen OK, Tonstad S, Røsby O, Urdal P, Ose L (1995)
    Identification of the apo B-3500 mutation in the Norwegian population
    Scand J Clin Lab Invest, 55 (3), 217-21
    PubMed 7638555
11. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L (1995)
    Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia
    Hum Genet, 96 (2), 241-2
    PubMed 7635482
12. Leren TP, Sundvold H, Rødningen OK, Tonstad S, Solberg K, Ose L, Berg K (1995)
    Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia
    Hum Genet, 95 (6), 671-6
    PubMed 7789953
13. Lothe RA, Andersen SN, Hofstad B, Meling GI, Peltomäki P, Heim S, Brøgger A, Vatn M, Rognum TO, Børresen AL (1995)
    Deletion of 1p loci and microsatellite instability in colorectal polyps
    Genes Chromosomes Cancer, 14 (3), 182-8
    PubMed 8589034
14. Lothe RA, Børresen AL (1995)
    [Early diagnosis of colorectal tumors]
    Tidsskr Nor Laegeforen, 115 (26), 3231-2
    PubMed 7482447
15. Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995)
    Molecular genetic changes in human male germ cell tumors
    Lab Invest, 73 (5), 606-14
    PubMed 7474934
16. Lothe RA, Slettan A, Saeter G, Brøgger A, Børresen AL, Nesland JM (1995)
    Alterations at chromosome 17 loci in peripheral nerve sheath tumors
    J Neuropathol Exp Neurol, 54 (1), 65-73
    PubMed 7815081
17. Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R (1995)
    TP53 gene mutations and protein accumulation in primary vaginal carcinomas
    Br J Cancer, 72 (1), 129-33
    PubMed 7599041
18. Steen VM, Andreassen OA, Daly AK, Tefre T, Børresen AL, Idle JR, Gulbrandsen AK (1995)
    Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology
    Pharmacogenetics, 5 (4), 215-23
    PubMed 8528268
19. Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE (1995)
    TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
    Eur J Cancer, 31A (11), 1856-61
    PubMed 8541113

Publications 1994

1. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen AL (1994)
   Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility
   Hum Genet, 94 (6), 665-70
   PubMed 7989041
2. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P (1994)
   Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations
   Cancer Res, 54 (15), 4200-6
   PubMed 8033152
3. Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O (1994)
   TP53 allele loss, mutations and expression in malignant melanoma
   Br J Cancer, 69 (2), 253-9
   PubMed 7905277
4. Gatti RA, Lange E, Rotman G, Chen X, Uhrhammer N, Liang T, Chiplunkar S, Yang L, Udar N, Dandekar S, Sheikhavandi S, Wang Z, Yang HM, Polikow J, Elashoff M, Teletar M, Sanal O, Chessa L, McConville C, Taylor M, Shiloh Y, Porras O, Borresen AL, Wegner RD, Curry C et al. (1994)
   Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an approximately 850 kb region on chromosome 11q23.1
   Int J Radiat Biol, 66 (6 Suppl), S57-62
   PubMed 7836853
5. Heimdal KR, Lothe RA, Fosså SD, Børresen AL (1994)
   Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer
   Int J Cancer, 58 (4), 523-6
   PubMed 8056449
6. Helland A, Børresen AL, Kristensen G, Rønningen KS (1994)
   DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis
   Cancer Epidemiol Biomarkers Prev, 3 (6), 479-86
   PubMed 8000298
7. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC (1994)
   Database of p53 gene somatic mutations in human tumors and cell lines
   Nucleic Acids Res, 22 (17), 3551-5
   PubMed 7937055
8. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L (1994)
   Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
   Atherosclerosis, 111 (2), 175-82
   PubMed 7718019
9. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J (1994)
   Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma
   J Clin Oncol, 12 (5), 925-30
   PubMed 8164043
10. Nesland JM, Børresen AL, Andersson LC (1994)
    [Molecular pathology. A new diagnostic dimension]
    Tidsskr Nor Laegeforen, 114 (26), 3047-8
    PubMed 7974419
11. Rosenberg C, Andersen TI, Nesland JM, Lier ME, Brøgger A, Børresen AL (1994)
    Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques
    Cancer Genet Cytogenet, 75 (1), 1-5
    PubMed 8039157
12. Rosenberg C, Janson M, Nordeskjöld M, Børresen AL, Vianna-Morgante AM (1994)
    Intragenic reorganization of RB1 in a complex (4;13) rearrangement demonstrated by FISH
    Cytogenet Cell Genet, 65 (4), 268-71
    PubMed 8258302
13. Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A (1994)
    p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer
    Cancer Res, 54 (6), 1551-5
    PubMed 8137262
14. Seruca R, David L, Castedo S, Veiga I, Børresen AL, Sobrinho-Simões M (1994)
    p53 alterations in gastric carcinoma: a study of 56 primary tumors and 204 nodal metastases
    Cancer Genet Cytogenet, 75 (1), 45-50
    PubMed 8039163
15. Solberg K, Rødningen OK, Tonstad S, Ose L, Leren TP (1994)
    Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene
    Scand J Clin Lab Invest, 54 (8), 605-9
    PubMed 7709162
16. Tefre T, Daly AK, Armstrong M, Leathart JB, Idle JR, Brøgger A, Børresen AL (1994)
    Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls
    Pharmacogenetics, 4 (2), 47-57
    PubMed 8081413
17. Verwest AM, de Leeuw WJ, Molijn AC, Andersen TI, Börresen AL, Mullaart E, Uitterlinden AG, Vijg J (1994)
    Genome scanning of breast cancers by two-dimensional DNA typing
    Br J Cancer, 69 (1), 84-92
    PubMed 8286216

Publications 1993

1. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL (1993)
   Prognostic significance of TP53 alterations in breast carcinoma
   Br J Cancer, 68 (3), 540-8
   PubMed 8102535
2. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
   p53 abnormalities in different subtypes of human sarcomas
   Cancer Res, 53 (3), 468-71
   PubMed 8425179
3. Børresen AL (1993)
   [The 1993 Nobel Prize in chemistry--polymerase chain reaction and directed mutagenesis]
   Tidsskr Nor Laegeforen, 113 (30), 3668-9
   PubMed 8278946
4. Condie A, Eeles R, Borresen AL, Coles C, Cooper C, Prosser J (1993)
   Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques
   Hum Mutat, 2 (1), 58-66
   PubMed 8477265
5. Heimdal K, Lothe RA, Lystad S, Holm R, Fosså SD, Børresen AL (1993)
   No germline TP53 mutations detected in familial and bilateral testicular cancer
   Genes Chromosomes Cancer, 6 (2), 92-7
   PubMed 7680893
6. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL (1993)
   Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas
   J Pathol, 171 (2), 105-14
   PubMed 8283348
7. Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM (1993)
   Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri
   J Pathol, 169 (1), 21-6
   PubMed 8433212
8. Hovig E, Mullaart E, Børresen AL, Uitterlinden AG, Vijg J (1993)
   Genome scanning of human breast carcinomas using micro- and minisatellite core probes
   Genomics, 17 (1), 66-75
   PubMed 8104870
9. Leren TP, Rødningen OK, Røsby O, Solberg K, Berg K (1993)
   Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads
   Biotechniques, 14 (4), 618-23
   PubMed 8476605
10. Leren TP, Solberg K, Rødningen OK, Ose L, Tonstad S, Berg K (1993)
    Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene
    PCR Methods Appl, 3 (3), 159-62
    PubMed 8118396
11. Leren TP, Solberg K, Rødningen OK, Røsby O, Tonstad S, Ose L, Berg K (1993)
    Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop
    Hum Genet, 92 (1), 6-10
    PubMed 8103503
12. Lothe RA, Hastie N, Heimdal K, Fosså SD, Stenwig AE, Børresen AL (1993)
    Frequent loss of 11p13 and 11p15 loci in male germ cell tumours
    Genes Chromosomes Cancer, 7 (2), 96-101
    PubMed 7687459
13. Lothe RA, Saeter G, Danielsen HE, Stenwig AE, Høyheim B, O'Connell P, Børresen AL (1993)
    Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1)
    Pathol Res Pract, 189 (4), 465-71; discussion 471-4
    PubMed 8351250
14. Meling GI, Lothe RA, Børresen AL, Graue C, Hauge S, Clausen OP, Rognum TO (1993)
    The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17
    Br J Cancer, 67 (1), 88-92
    PubMed 8094008
15. Meling GI, Lothe RA, Børresen AL